| HDAC6 | Clinical trial target | Histone deacetylase 6;HD6 | Myeloma;Multiple myeloma;Autoimmune diseases | ACY-1215 | 8-Oxo-8-phenyl-octanoic acid;7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one;santacruzamate A;N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide;N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide;7-Mercapto-heptanoic acid phenylamide;5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione;5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide;Cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-);7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one;PSAMMAPLIN A;N-(quinolin-8-yl)-6-(sulfamoylamino)hexanamide;Octanedioic acid hydroxyamide pyridin-2-ylamide;Cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-);N-[5-(Formyl-hydroxy-amino)-pentyl]-benzamide;N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide;N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide;N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide;droxinostat;6-Phenoxy-hexane-1-thiol;Cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-);(S)-2-Amino-N-cyclopentyl-7-mercaptoheptanamide;(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one;N-(quinolin-3-yl)-6-(sulfamoylamino)hexanamide;Cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-);6-phenylsulfanylhexanoic acid hydroxamide;N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide;Cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-);Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-);Tubacin;7-Mercapto-heptanoic acid quinolin-3-ylamide;N-Hydroxy-4-(pentanoylamino-methyl)-benzamide;N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide;IKH-25;8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one;Cyclostellettamine derivative;Cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-);Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-);NQN-1;ST-2741;N-phenyl-6-(sulfamoylamino)hexanamide;7-Mercapto-heptanoic acid pyridin-3-ylamide;Cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-);9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide;4-Benzoylamino-N-hydroxy-benzamide;N-Hydroxy-4-phenylacetylamino-benzamide;8-Oxo-8-phenyl-octanoic acid hydroxyamide;N-(2-Mercapto-ethyl)-N'-phenyl-succinamide;9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one;6-benzenesulfonylhexanoic acid hydroxamide;ST-2987;Cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-);4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide;N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide;7-Mercapto-heptanoic acid biphenyl-3-ylamide;N-(6-Hydroxycarbamoyl-hexyl)-benzamide;6-(2-Bromo-acetylamino)-hexanoic acid phenylamide;ST-3050;Octanedioic acid bis-hydroxyamide;Cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-);6-Mercapto-hexanoic acid phenylamide;N-(quinolin-6-yl)-6-(sulfamoylamino)hexanamide;N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide;4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide;7-Mercapto-heptanoic acid biphenyl-4-ylamide;N-(6-Mercapto-hexyl)-benzamide;7-Mercapto-heptanoic acid benzothiazol-2-ylamide;nexturastat A;N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide;8-Mercapto-octanoic acid phenylamide;Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester;Octanedioic acid hydroxyamide pyridin-4-ylamide;7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one;4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide;compound 16;6-(9H-carbazol-9-yl)-N-hydroxyhexanamide;ST-2986;7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one;compound 7d;4-Phenylbutyrohydr | |